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Abstract
Background: Compared to other breast surgery methods, the accurate determination of pathologic margin in oncoplastic tech-
nique can affect its development and further employment of this technique. The current study aimed at evaluating positive patho-
logic margin after oncoplastic surgery and comparing it to that of the conventional breast-conserving surgery.
Methods: The current cross sectional and prospective study enrolled patients with breast cancer referring to the surgical clinic of
Tehran Cancer Institute from 2010 to 2013. In this study, patients with breast cancer were evaluated based on the type of surgery
(oncoplastic or conventional breast-conserving) they had undergone. Accordingly, the positive or negative result of the margin
surgery was compared between the groups.
Results: In the current study, 317 patients with breast cancer underwent the surgery during the study period (154 patients in the on-
coplastic and 163 patients in the conventional breast-conserving surgery groups). The highest frequency in the oncoplastic surgery
belonged to Omega method (27.3%). The pathological evaluations after surgery showed ductal breast carcinoma in most of the cases
in both groups (oncoplastic surgery = 94.2%; conventional breast-conserving surgery = 90.8%; P = 0.053). Positive margin in on-
coplastic surgery and conventional breast-conserving surgery groups were 10.4% and 18.4%, respectively (P = 0.043). Among the 317
studied subjects, 14 relapse cases were observed; in 7 cases, mastectomy and in the rest, re-excision were conducted. Two out of 14
cases belonged to the positive margin group.
Conclusions: Using oncoplastic surgery as a method for breast surgery may play an important role in reducing the prevalence of
positive margins compared to the conventional breast-conserving surgery.
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1. Background
In recent years, breast cancer surgery gradually tends
from radical techniques toward complete tumor resection
with the conservation of normal parenchymal tissue. In
addition, to achieve the desired oncological results, this
change may play an important role to get good cosmetic
outcomes and improve quality of life in patients (1, 2). New
innovations are created in the mentioned surgical tech-
niques, emphasizing more on the cosmetic results after
surgery through the reconstruction of partial mastectomy,
called oncoplastic (3-5). Different studies showed desir-
able and appropriate therapeutic results for this method
such as good cosmetic outcomes, better control over tu-
mor margin, high satisfaction of patients, and high proba-
bility of breast conservation (6-11).
Candidates for breast oncoplastic surgery should be
evaluated from different aspects by the surgeon before the
operation. First, the location and size of removing tissue
and the proper method of reconstruction for the defected
location should be determined. At this stage, it can be
determined if the patients is a suitable candidate for the
surgery or not. The appropriate therapeutic program be-
fore the surgery may increase the capability of the surgeon
regarding the type of cuts and size of removing tissue. The
size of tumor is reduced in these patients after chemother-
apy and they can be placed on the list of candidates for on-
coplastic surgery (12-14).
The reconstruction of surgical site in oncoplastic tech-
nique lets the surgeon remove bigger tumors, using this
method with breast-conserving; they were previously re-
moved through mastectomy (15, 16). Breast reconstruction
during the surgery depends on the ration of breast size
to the tumor volume. In the smaller breasts, less glandu-
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lar tissues are provided for the surgeon for reconstruction;
hence, it is more probable to use local flaps for these pa-
tients. Mastectomy flap surgery has good cosmetic out-
comes for patients with larger tumors (the resection ra-
tion ≥ 1/5) compared to the method conserving smaller
breasts. In addition, the breasts’ symmetry should be
considered; however, there is a disagreement regarding
the restoration time to maintain symmetry in breasts (17-
21). Considering the 0.1% to 5% probability of the metas-
tasis to the opposite breast and also significant decrease
in the level of breast cancer incidence in females over 50
years due to reduction in breast size may reduce the pos-
sibility of cancer incidence (22-26). Evaluations show the
15% to 30% complications after oncoplastic in the patients.
These complications are skin flap necrosis, nipple or areole
necrosis, seroma, hematoma, infection, open wound, and
fat tissue necrosis. The most prevalent complication in T-
reverse or Wise pattern techniques is delay in the restora-
tion of wound edge due to decrease in vessel perfusion.
Since the duration of the oncoplastic surgery is longer
than those of the other methods, the candidates should be
selected carefully (27, 28).
The hypothesis of oncoplastic surgery is that local
restoration may affect the recurrence of illness and its di-
agnosis. Different studies conducted in this regard did not
confirm the hypothesis and indicated that the rate of tu-
mor recurrence was lower than that of the conventional
breast-conserving surgery (29).
The current study aimed at evaluating the positive
pathology margin after oncoplastic surgery and compared
it with that of the conventional breast-conserving surgery.
2. Methods
The current cross sectional prospective study was con-
ducted on patients with breast cancer referring to the sur-
gical clinic of Tehran cancer institute from 2010 to 2013.
This study was approved by ethics committee of Tehran
Cancer Institute.
In the current study, patients with breast cancer were
evaluated based on the type of surgery (oncoplastic and/or
conventional breast-conserving) they underwent. The first
result, which was compared between the groups, was the
positive or negative surgical margin. The positive margin
was defined in the current study as follows: 1) the tumor
cell in the periphery or the closed tumor; 2) ductal car-
cinoma in-situ (DCIS) positive in periphery. The patients
were followed-up for 2 years and the therapeutic results
were evaluated. Inclusion criteria were as follow: stage I
to III cancer of the breast incidence, unilateral cancer and
healthy opposite breast, undergoing oncoplastic, or con-
ventional breast-conserving surgeries.
The sample size was calculated by formula, using the
results in Kaur et al.’s study (30).
(1)n =
(
Z1−α
2
+ Z1−β
)2
(P1 (1− P1) + P2 (1− P2))
(P1 − P2)2
The analyses were performed, using the SPSS software
for Windows, version 21. The data were presented as pro-
portion, mean, and conventional deviation. We used Chi-
square and Fisher’s exact test for quantitative and qualita-
tive variables. P values less than 0.05 were considered sig-
nificant.
3. Results
The current study classified 317 patients into 2 groups
(154 subjects in the oncoplastic surgery and 163 subjects
in the conventional breast-conserving surgery). The clin-
ical features of the patients are presented in Table 1. The
most prevalent type of the oncoplastic surgery was Omega
(27.3%). The prevalence of different types of the oncoplastic
surgery is illustrated in Figure 1. The pathological indices
of the studied tumors were evaluated separately (Table 2).
Table 1. The Clinical Features of the Patients
Variables Oncoplastic
Group (N = 154)
(100%)
Conventional
Group (N = 163)
(100%)
P Value
Tumor location 0.002
Central 9 (5.8) 6 (3.7)
6 11 (7.1) 9 (5.5)
12 25 (16.2) 13 (8.0)
UOQ 57 (37.0) 88 (54.0)
UIQ 25 (16.2) 37 (22.7)
LOQ 15 (9.7) 5 (3.1)
LIQ 12 (7.8) 5 (3.1)
Biopsy 0.001
CNB 111 (60.0) 105 (64.4)
Open
Biopsy
43 (47.2) 43 (47.2)
FNA 0 (0.0) 0 (0.0)
Frozen in
Surgery
0 (0.0) 0 (0.0)
Axillary lym-
phadenopathy
0.000
SLNB 84 (54.5) 51 (31.3)
ALNB 42 (27.3) 76 (46.6)
SLNB +
ALNB
28 (18.2) 36 (22.1)
Frozen margin 0.043
Positive 16 (10.4) 30 (18.4)
Negative 138 (89.6) 133 (81.6)
Therapeutic actions following the surgery were mas-
tectomy, re-excision, and radiotherapy. Out of 16 subjects
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Figure 1. The prevalence of different types of the oncoplastic surgery
Table 2. The Pathological Indexes of the Studied Tumors
Pathological
Variables
Oncoplastic
Group (N =154)
(100%)
Conventional
(Group N = 163)
(100%)
P Value
Grade 0.002
I 31 (20.1) 41 (25.2)
II 97 (63.0) 89 (54.6)
III 26 (16.9) 33 (20.2)
Tumor Size 0.001
T1 48 (31.2) 57 (35.0)
T2 98 (63.6) 101 (62.0)
T3 8 (5.2) 5 (3.0)
Node 0.000
Positive 47 (30.5) 56 (34.4)
Negative 107 (69.5) 107 (65.6)
Position 0.043
Lateral 5 (31.3) 6 (20.0)
Medial 1 (6.3) 3 (10.0)
Superior 8 (50.0) 10 (33.3)
Inferior 1 (6.3) 5 (16.7)
All Margin 1 (6.3) 6 (20.0)
in the oncoplastic group with positive margin, 2 subjects
did not refer. Hence, 14 subjects in the oncoplastic group
and 30 subjects in the conventional breast-conserving
surgery group were medically followed-up and the results
are shown in Table 3.
Table 3. The Outcome of Tumors with Positive Margin
Variable Oncoplastic Group (N =
14) (100%)
Conventional Group (N =
30) (100%)
Mastectomy 8 (57.1) 12 (40.0)
Re-excision 5 (35.7) 10 (33.3)
Radiotherapy 1 (7.2) 8 (26.7)
There were 14 relapses among the 317 subjects; mastec-
tomy was conducted for 7 cases and re-excision was per-
formed for the rest 7 cases. Two relapse cases out of 14 be-
longed to positive margin group.
The pathological evaluations after surgery showed that
most of the subjects in 2 groups were ductal (oncoplastic
= 94.2%; conventional = 90.8%; P = 0.053). The distribution
of pathology margins is shown in Table 4. Positive mar-
gin in oncoplastic group was 10.4% and in the conventional
breast-conserving surgery group was 18.4% (P = 0.043).
Table 4. The Distribution of Pathology Margins
Pathological Index Oncoplastic Group (N
= 154) (100%)
Conventional Group
(N = 163) (100%)
Tumor margin
Positive 6 (3.9) 13 (7.9)
Negative 148 (96.1) 150 (92.1)
Tumor closed
Positive 6 (3.9) 5 (3.1)
Negative 148 (96.1) 158 (96.9)
DCIS
Positive 2 (1.2) 8 (4.9)
Negative 152 (98.8) 155 (95.1)
DCIS closed
Positive 2 (1.2) 4 (2.5)
Negative 152 (98.8) 159 (97.5)
4. Discussion
In the current study, 10.4% of the cases in the oncoplas-
tic group needed surgery, while the rate for the conven-
tional breast-conserving surgery was 18.4%, which could
be because of more removal of breast tissue in breast-
conserving and maintenance of the natural appearance of
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it in the oncoplastic surgeries. Similar results were also ob-
tained in the similar studies. In a study conducted by Ma-
trai et al. (31) the data of 60 cases with oncoplastic and 60
cases with conventional breast-conserving surgeries were
compared. The size of tumor, the prevalence of quadran-
tectomy, metastasis to the local lymph nodes, and adjuvant
chemotherapy were significantly higher in the oncoplas-
tic group compared to the other group. Longer surgery
time, higher weight of the cases, and less positive margin
cases were reported in the oncoplastic group compared to
the other group. There was a significant statistical differ-
ence between the groups regarding the prevalence of com-
plications and adjuvant therapy onset time interval. The
surgery cosmetic outcomes were significantly better in the
oncoplastic group compared to the other group. Also, the
level of pain in hand, shoulders, and chest were lower in
the oncoplastic group. Totally, the researchers reported
that the oncoplastic surgery was preferred to the conven-
tional breast-conserving surgery regarding the extraction
of breast tumors, even big ones. Oncoplastic surgery with
less complication does not cause any delay in the adjuvant
therapies; therefore, this method does not increase the risk
of recurrence. Likewise, the good cosmetic outcomes of
this method should also be considered (31).
Although breast oncoplastic surgeries let the surgeon
perform a wider resection of tissue, the conducted tissue
repair can make the evaluation of positive margin diffi-
cult. In the conducted studies, the rates of positive mar-
gin were reported as 2.7% to 22%, which were in association
with the higher stages of cancer, positive lymph nodes,
and positive lymphovascular invasion, using neoadjuvant
chemotherapy, larger T, estrogen receptor, and lower age
(32). In many oncoplastic margin methods, dermoglandu-
lar flaps are used, which transfer breast tissue from one
side to another. If the surgery should be followed-up in the
second stage, due to the malignancy on the peripheries, it
turns into a challenge and makes the decision making for
the cuts difficult (33). Frozen section is also used as a diag-
nosis method to evaluate tumor margin during the surg-
eries. Compared with those of paraffin method, the sensi-
tivity and the accuracy of this method were 83% and 96%,
respectively (34).
In another study, 440 cases of conventional breast-
conserving surgery and 150 cases of oncoplastic surgery (in
146 females) were compared and the results showed that
the rate of second surgery in the oncoplastic group was
lower than that of the conventional one (2.7% compared to
13.4%). Local relapse in the conventional and the oncoplas-
tic groups were 2.7% and 1.3%, respectively. Authors con-
cluded that the probability of the second surgery in the
oncoplastic group was lower than that of the conventional
group (29).
In a study carried out by Down et al. (35) the con-
ventional breast-conserving and the oncoplastic surgeries
were employed for 121 and 37 subjects, respectively. In
their study, the size of tumor in the groups with conven-
tional and oncoplastic surgeries were 23.9 and 17.6 mm
respectively, which showed statistically significant differ-
ence (P = 0.002). Also, the mean weight and size of tumor
in the subjects of oncoplastic and conventional surgery
groups were 231.1 and 58.1 g, respectively. The rate of mar-
gin in the oncoplastic and conventional surgery groups
were 14.3 and 6.1 mm, respectively, which showed statisti-
cally significant difference (P = 0.00001). The suitable mar-
gin for the oncoplastic group can reduce the rate of need
for the second surgery to 5.4%, compared to 28.9% rate of
surgery need in the conventional group. The oncoplastic
breast-conserving surgery is more successful compared to
the conventional surgery regarding the treatment of large
breast tumors by creating safe and suitable margin, which
reduces the risk of subsequent surgeries in the positive
margin subjects.
The present study proposed surgical therapy to the
cases with positive margin. The radiotherapy was per-
formed as an alternative treatment to the cases, who did
not agree to the surgery (9 out of 44 cases with positive
margin). No relapse was reported in the radiotherapy
group during the two-year follow-up.
In the current study, 89.6% and 81.6% of the cases in the
oncoplastic surgery and conventional breast-conserving
surgery groups had negative margin (P= 0.043), which was
compatible with the result of the other studies. Kaur et al.
(30) evaluated 60 patients with breast cancer in 2 groups
of oncoplastic surgery and conventional surgery. In the on-
coplastic surgery and conventional surgery groups, 80.4%
and 56.7% of the cases had negative margin, respectively
(P = 0.05). The average distance between the surgical mar-
gin of the oncoplastic group and that of the conventional
group were 8.5 and 6.5 mm, respectively, which had no sta-
tistically significant differences (P = 0.074). Researchers re-
ported that the oncoplastic surgery was preferred to the
conventional surgery since more size of tissue with higher
margin can be removed by this method and it reduces the
risk of positive margin (30).
The main objective of this study was to compare surgi-
cal margin after breast cancer surgery between oncoplas-
tic technique and conventional breast-conserving surgery.
Positive margin in oncoplastic group was less than that of
in conventional breast-conserving surgery group (10.4 % vs
18.4 %), meaning that the oncoplastic method, as a breast
cancer surgery, can play an important role in reducing pos-
itive margin cases, compared to the conventional breast-
conserving surgery.
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